Clinical Trial Update: Single Dose Flecainide for Early Sinus Rhythm Conversion of Perioperative Atrial Fibrillation After Noncardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a single-dose flecainide to convert perioperative atrial fibrillation after noncardiac surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• flecainide (flecainide)

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation, Surgery | Phase 4 | Status: WITHDRAWN